A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication - PubMed (original) (raw)

A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication

R J Samulski et al. J Virol. 1987 Oct.

Abstract

A recombinant plasmid carrying an infectious adeno-associated viral genome was constructed that differs in several key respects from previously described recombinants. First, the vector is pEMBL8(+), which allows isolation of viral plus and minus strands. Second, the inserted viral sequences contain two XbaI cleavage sites that flank the viral coding domain. These inserts do not affect replication of the virus, and they allow nonviral sequences to be easily inserted between the cis-acting terminal repeats of adeno-associated virus. Third, the viral genome is flanked by PvuII cleavage sites that allow the entire, infectious viral chromosome to be excised from plasmid sequences in vitro. Viral DNA was replicated more efficiently within adenovirus-infected 293 cells if it was excised from the vector with PvuII before transfection. Presumably, the increased efficiency reflects bypass of the excision step which must normally precede replication when a recombinant plasmid enters the nucleus. The ability to bypass the excision step was exploited to search for a viral function required specifically for excision of the viral genome from the integrated state. None of the mutants tested identified a gene product required for excision that was not also essential for replication. The ability to produce pure populations of viral plus and minus strands was used to demonstrate that both strands are infectious.

PubMed Disclaimer

Cited by

Development of an AAV DNA-based synthetic vector for the potential gene therapy of hemophilia in children.
Shoti J, Qing K, Srivastava A. Shoti J, et al. Front Microbiol. 2022 Oct 6;13:1033615. doi: 10.3389/fmicb.2022.1033615. eCollection 2022. Front Microbiol. 2022. PMID: 36274690 Free PMC article.
T160‐phosphorylated CDK2 defines threshold for HGF dependent proliferation in primary hepatocytes.
Mueller S, Huard J, Waldow K, Huang X, D'Alessandro LA, Bohl S, Börner K, Grimm D, Klamt S, Klingmüller U, Schilling M. Mueller S, et al. Mol Syst Biol. 2015 Mar;11(3):795. doi: 10.15252/msb.20156032. Mol Syst Biol. 2015. PMID: 26148348 Free PMC article.
Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates.
Davis MD, Wu J, Owens RA. Davis MD, et al. J Virol. 2000 Mar;74(6):2936-42. doi: 10.1128/jvi.74.6.2936-2942.2000. J Virol. 2000. PMID: 10684315 Free PMC article.
Effects of rAAV-Mediated sox9 Overexpression on the Biological Activities of Human Osteoarthritic Articular Chondrocytes in Their Intrinsic Three-Dimensional Environment.
Daniels O, Frisch J, Venkatesan JK, Rey-Rico A, Schmitt G, Cucchiarini M. Daniels O, et al. J Clin Med. 2019 Oct 7;8(10):1637. doi: 10.3390/jcm8101637. J Clin Med. 2019. PMID: 31591319 Free PMC article.
Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood.
Zhou SZ, Cooper S, Kang LY, Ruggieri L, Heimfeld S, Srivastava A, Broxmeyer HE. Zhou SZ, et al. J Exp Med. 1994 Jun 1;179(6):1867-75. doi: 10.1084/jem.179.6.1867. J Exp Med. 1994. PMID: 7515101 Free PMC article.

References

1. J Mol Biol. 1967 Jun 14;26(2):365-9 - PubMed
1. J Exp Med. 1967 May 1;125(5):755-65 - PubMed
1. J Natl Cancer Inst. 1968 Aug;41(2):351-7 - PubMed
1. Proc Natl Acad Sci U S A. 1969 Nov;64(3):863-9 - PubMed
1. J Virol. 1970 Jun;5(6):693-9 - PubMed

A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication - PubMed (original) (raw)